Hosted by MJH Life Sciences COVID-19 Coalition, this free webinar will feature expert insight into the myths and controversies of the global pandemic.
Mistruths and misconceptions surrounding the COVID-19 pandemic continue to spread, including who’s at risk of contracting the virus, certain drugs to counteract its effects, and so on. To dispel the many mistruths and “un-facts” surrounding the virus, MJH Life Sciences COVID-19 Coalition will host a free, 1-hour webinar at 6 p.m. EST on Tuesday, Sept. 29.
‘Fact or Fiction? COVID-19 Myths and Controversies’ will feature a panel of top-tier experts, including infection prevention epidemiologists, virologists, and research specialists.
Register here and learn more about the COVID-19 Coalition.
Surge of antidepressant use seen among female adolescents during COVID-19
March 7th 2024A study revealed a significant increase in antidepressant prescriptions among adolescents and young adults during the COVID-19 pandemic, particularly among female adolescents, indicating exacerbation of pre-existing mental health challenges.
Read More
Contemporary OB/GYN Senior Editor Angie DeRosa gets insight on the current state of COVID-19 from Christina Han, MD, division director of maternal-fetal medicine at the University of California, Los Angeles, and member of its COVID-19 task force. Han is an active member of the Society for Maternal-Fetal Medicine and discusses the issues on behalf of SMFM.
Listen
COVID-19 vaccination during pregnancy not linked to preterm birth
January 31st 2024A systematic review of 6 studies revealed that COVID-19 vaccination during pregnancy does not significantly increase the risk of preterm birth, providing crucial insights for public health policies and offering reassurance to healthcare providers and expectant mothers.
Read More
Maternal COVID-19 vaccination deemed safe for infant neurodevelopment up to 18 months
January 23rd 2024A recent study found that in utero exposure to maternal COVID-19 vaccination poses no increased risk for neurodevelopmental impairment in infants up to 18 months of age, addressing concerns about the impact of vaccine exposure on unborn children.
Read More